Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1931158156;58157;58158 chr2:178594563;178594562;178594561chr2:179459290;179459289;179459288
N2AB1767053233;53234;53235 chr2:178594563;178594562;178594561chr2:179459290;179459289;179459288
N2A1674350452;50453;50454 chr2:178594563;178594562;178594561chr2:179459290;179459289;179459288
N2B1024630961;30962;30963 chr2:178594563;178594562;178594561chr2:179459290;179459289;179459288
Novex-11037131336;31337;31338 chr2:178594563;178594562;178594561chr2:179459290;179459289;179459288
Novex-21043831537;31538;31539 chr2:178594563;178594562;178594561chr2:179459290;179459289;179459288
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAT
  • RefSeq wild type template codon: CTA
  • Domain: Fn3-28
  • Domain position: 28
  • Structural Position: 30
  • Q(SASA): 0.228
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/H None None 0.999 N 0.69 0.363 0.391775403332 gnomAD-4.0.0 1.59247E-06 None None None None I None 0 0 None 0 0 None 0 0 2.86048E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.9285 likely_pathogenic 0.8913 pathogenic -0.818 Destabilizing 0.993 D 0.628 neutral N 0.494045397 None None I
D/C 0.9885 likely_pathogenic 0.9814 pathogenic -0.371 Destabilizing 1.0 D 0.715 prob.delet. None None None None I
D/E 0.9333 likely_pathogenic 0.9119 pathogenic -0.742 Destabilizing 0.977 D 0.413 neutral N 0.495829369 None None I
D/F 0.9929 likely_pathogenic 0.9869 pathogenic -0.557 Destabilizing 1.0 D 0.711 prob.delet. None None None None I
D/G 0.9274 likely_pathogenic 0.8895 pathogenic -1.185 Destabilizing 0.955 D 0.5 neutral N 0.519760202 None None I
D/H 0.9616 likely_pathogenic 0.9303 pathogenic -0.904 Destabilizing 0.999 D 0.69 prob.neutral N 0.493489192 None None I
D/I 0.9844 likely_pathogenic 0.9728 pathogenic 0.166 Stabilizing 0.998 D 0.721 prob.delet. None None None None I
D/K 0.9862 likely_pathogenic 0.977 pathogenic -0.607 Destabilizing 0.995 D 0.588 neutral None None None None I
D/L 0.9756 likely_pathogenic 0.9606 pathogenic 0.166 Stabilizing 0.998 D 0.707 prob.neutral None None None None I
D/M 0.9931 likely_pathogenic 0.9878 pathogenic 0.745 Stabilizing 1.0 D 0.706 prob.neutral None None None None I
D/N 0.4156 ambiguous 0.2704 benign -0.991 Destabilizing 0.117 N 0.193 neutral N 0.508766027 None None I
D/P 0.9834 likely_pathogenic 0.9742 pathogenic -0.138 Destabilizing 0.999 D 0.709 prob.delet. None None None None I
D/Q 0.9804 likely_pathogenic 0.9687 pathogenic -0.837 Destabilizing 0.998 D 0.701 prob.neutral None None None None I
D/R 0.9849 likely_pathogenic 0.9758 pathogenic -0.526 Destabilizing 0.995 D 0.722 prob.delet. None None None None I
D/S 0.7149 likely_pathogenic 0.6034 pathogenic -1.354 Destabilizing 0.966 D 0.491 neutral None None None None I
D/T 0.8668 likely_pathogenic 0.7854 pathogenic -1.039 Destabilizing 0.995 D 0.571 neutral None None None None I
D/V 0.9605 likely_pathogenic 0.931 pathogenic -0.138 Destabilizing 0.997 D 0.722 prob.delet. N 0.504503103 None None I
D/W 0.9982 likely_pathogenic 0.9965 pathogenic -0.416 Destabilizing 1.0 D 0.712 prob.delet. None None None None I
D/Y 0.9477 likely_pathogenic 0.9024 pathogenic -0.316 Destabilizing 1.0 D 0.709 prob.delet. D 0.537864457 None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.